Homocysteine is potential serological marker for predicting the risk of deep venous thrombosis of the lower extremities in patients received operation of lower limb fracture
The aim of the study is to investigate the correlations among serum homocysteine (Hcy), D-dimer, and the risk of developing deep venous thrombosis (DVT) of the lower extremities in patients who underwent operation for lower limb fracture.
Guardado en:
Autores principales: | Chen Xiao, Zhang Weiran, Huang Jingmin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2669ad4d53a94a06ac2161e18d94307a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current state of treatment for lower extremity acute deep venous thrombosis (a literature review)
por: A. O. Nykonenko, et al.
Publicado: (2021) -
Clinical significance of serum homocysteine as a biomarker for early diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients
por: Ye Bin, et al.
Publicado: (2021) -
INCIDENCE OF DEEP VENOUS THROMBOSIS IN LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT THROMBOPROPHYLAXIS
por: Muhammad Imran, et al.
Publicado: (2018) -
Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in Japan
por: Seiya Oba, et al.
Publicado: (2021) -
Prediction of central venous catheter-associated deep venous thrombosis in pediatric critical care settings
por: Haomin Li, et al.
Publicado: (2021)